Novocure Announces Upcoming Investor Events

On September 2, 2026 Novocure (NASDAQ: NVCR) reported that management will participate in two upcoming investor events.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 21st Annual Healthcare Conference, September 9, 2026: Frank Leonard, Chief Executive Officer, will take part in a fireside chat at 10:15 a.m. ET, as well as one-on-one meetings with investors.
Morgan Stanley 24th Annual Global Healthcare Conference, September 14, 2026: Mr. Leonard and Christoph Brackmann, Chief Financial Officer, will take part in a fireside chat at 3:20 p.m. ET, as well as one-on-one meetings with investors.
Live audio webcasts of these presentations can be accessed from Novocure’s Investor Relations website, investor.novocure.com, and will be available for replay for at least 14 days following the event.

(Press release, NovoCure, SEP 2, 2026, View Source [SID1234670558])